Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Peptidylprolyl isomerase H pseudogene 1 (PPIHP1) is classified as a pseudogene, meaning it is a genomic DNA sequence similar to a known gene but generally nonfunctional; it does not encode an active protein[2][1][4][8]. PPIHP1 is named for its similarity to the functional gene Peptidylprolyl isomerase H (PPIH), which encodes an enzyme involved in protein folding, but PPIHP1 itself lacks protein-coding potential and is not considered a drug target, receptor, enzyme, transporter, or biomarker[2]. Pseudogenes like PPIHP1 are often included in gene databases for annotation purposes, but they are distinct from functioning protein-coding genes and have no established roles as therapeutic targets, biological effectors, or disease markers[2][6]. Occasionally, pseudogenes can contribute to regulatory non-coding RNA networks, but no such function has been specifically attributed to PPIHP1 in the available literature.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Peptidylprolyl isomerase H pseudogene 1 (PPIHP1).